Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 1/20 | 0.59 |
| ▸ | PDGFRB | P09619 | 5/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 4/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.48 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.46 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.46 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.46 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31220211 | 0.80 | CYP1A2 (0.53) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL16512107 | 0.80 | CYP1A2 (0.53) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL32667946 | 0.78 | PDGFRB (0.77) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL2772360 | 0.78 | PDGFRB (0.77) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL3823001 | 0.77 | BIRC5 (0.65) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL18812500 | 0.77 | PDGFRB (0.61) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL29419045 | 0.77 | PDGFRB (0.56) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL2681535 | 0.77 | PDGFRB (0.56) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL3822952 | 0.77 | BIRC5 (0.59) | BIRC5PDGFRBPDGFRACYP2A6NISCH | |
| SCHEMBL19721615 | 0.75 | NPC1 (0.58) | BIRC5PDGFRBPDGFRACYP2A6NISCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367219-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| CN-101570536-A | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-11-04 | — | — | CN | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| EP-2055702-A1 | Anthracene-based compound and organic light emitting device employing the same | Samsung Electronics Co., Ltd. (KR) | 2009-05-06 | — | — | EP | disclosed |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | BIRC5 283/4885PDGFRB 4497/4885PDGFRA 4542/4885 |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | BIRC5 283/4885PDGFRB 4497/4885PDGFRA 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.